Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia
Journal of Clinical Oncology, vol. 43, pp. 65–74
Abstract
PURPOSE To determine the optimal daunorubicin dose and number of 7 + 3 induction cycles in newly diagnosed AML, this randomized controlled trial compared a once daily dose of 60 mg/m 2 with 90 mg/m 2 daunorubicin in the first 7 + 3 induction and one versus two cycles of 7 + 3 induction. PATIENTS AND METHODS Patients age 18-65 years with newly diagnosed AML were randomly assigned to 60 versus 90 mg/m 2 daunorubicin once daily plus cytarabine. Patients with marrow blasts below 5% on day 15 after first induction were randomly assigned to receive a second induction cycle or no second induction cycle. RESULTS Eight hundred and sixty-four patients with a median age of 52 years were randomly assigned. After a preplanned interim analysis showing no significant difference in response between 60 and 90 mg/m 2 , all consecutive patients received 60 mg/m 2 daunorubicin once daily. The proportion of good early responders was 44% versus 48% ( P = .983) with a composite complete remission (CRc) rate of 90% versus 89% after induction ( P = .691); the 3-year relapse-free survival (RFS) after 60 versus 90 mg/m 2 once daily was 54% versus 50% ( P = .561), and the 3-year overall survival (OS) was 65% versus 58% ( P = .242). Among 389 good responders, CRc rates at the end of induction were 87% after single induction and 85% after double induction. The 3-year RFS was 51% versus 60% (hazard ratio [HR], 1.3; P = .091), and the 3-year OS was 76% versus 75% after single versus double induction (HR, 1.0; P = .937). CONCLUSION The use of 90 mg/m 2 daunorubicin once daily in the context of classical 7 + 3 induction does not significantly improve early response and does not lead to higher remission rates or longer survival than 60 mg/m 2 once daily. In patients with a good early response after first induction, a second induction has only a limited impact on RFS and does not result in an OS benefit.
Authors 43
-
Technische Universität Dresden
Affiliation as printed
Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany
-
Affiliation as printed
Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany
-
Affiliation as printed
Department of Medicine A, University Hospital Münster, Münster, Germany
-
Affiliation as printed
Department of Medicine A, University Hospital Münster, Münster, Germany
-
Technische Universität Dresden
Affiliation as printed
Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany
-
Affiliation as printed
Department of Internal Medicine III, Chemnitz Hospital, Chemnitz, Germany
-
Affiliation as printed
Department of Internal Medicine III, Chemnitz Hospital, Chemnitz, Germany
-
Essen University Hospital · University of Duisburg-Essen
Affiliation as printed
Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
-
Essen University Hospital · University of Duisburg-Essen
Affiliation as printed
Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
-
Affiliation as printed
Department of Hematology, Robert-Bosch-Krankenhaus, Stuttgart, Germany
-
Affiliation as printed
Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
-
Nuremberg Hospital · Paracelsus Medizinische Privatuniversität
Affiliation as printed
Department of Internal Medicine V, Nuremberg Hospital North, Paracelsus Medical University, Nuremberg, Germany
-
Affiliation as printed
Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
-
Universitätsklinikum Gießen und Marburg
Affiliation as printed
Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany
-
Universitätsklinikum Gießen und Marburg
Affiliation as printed
Department of Internal Medicine, Hematology, Oncology and Immunology, University Hospital Marburg, Marburg, Germany
-
University Hospital Schleswig-Holstein
Affiliation as printed
Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
-
Institute of Haematology and Blood Transfusion
Affiliation as printed
Institute of Hematology and Blood Transfusion, Prague, Czech Republic
-
RWTH Aachen University · Universitätsklinikum Aachen
Affiliation as printed
Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital Aachen & CIO ABCD Aachen, RWTH Aachen, Aachen, Germany
Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital Aachen & CIO ABCD Aachen, RWTH Aachen, Aachen, Germany
-
Gemeinschaftsklinikum Mittelrhein
Affiliation as printed
Department of Hematology, Oncology and Palliative Care, Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany
-
Affiliation as printed
Department of Internal Medicine V, Universitätsklinikum Erlangen, Erlangen, Germany
-
Affiliation as printed
Klinik für Innere Medizin, Universitätsklinikum Jena, Jena, Germany
-
Affiliation as printed
Klinik für Innere Medizin, Universitätsklinikum Jena, Jena, Germany
-
Affiliation as printed
Klinik für Innere Medizin 1, Westpfalzklinikum, Kaiserslautern, Germany
-
Affiliation as printed
Department of Hemato-Oncology, Palacký University, Olomouc, Czech Republic
-
Affiliation as printed
II. Medizinische Klinik, Universitätsklinikum Augsburg, Augsburg, Germany
-
Affiliation as printed
II. Medizinische Klinik, Universitätsklinikum Augsburg, Augsburg, Germany
-
University Hospital Schleswig-Holstein
Affiliation as printed
Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
-
Heidelberg University · German Cancer Research Center · National Center for Tumor Diseases · Medizinische Fakultät Mannheim · University Hospital Leipzig · Leipzig University
Affiliation as printed
Department of Internal Medicine I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
Insitute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
NCT Trial Center, National Center of Tumor Diseases, German Cancer Research Center (DKFZ), Heidelberg, Germany
-
Affiliation as printed
Department of Hematology, Oncology and Palliative Care, Rems-Murr-Kliniken, Winnenden, Germany
-
Technische Universität Dresden
Affiliation as printed
Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany
-
Technische Universität Dresden
Affiliation as printed
Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany
-
Technische Universität Dresden
Affiliation as printed
Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany
-
Technische Universität Dresden
Affiliation as printed
Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany
-
Technische Universität Dresden
Affiliation as printed
Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany
-
University Hospital Schleswig-Holstein
Affiliation as printed
Department of Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
-
University Hospital Leipzig · Leipzig University
Affiliation as printed
Department of Internal Medicine I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
-
Technische Universität Dresden
Affiliation as printed
Agendix GmbH, Dresden, Germany
Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany
-
Affiliation as printed
Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
-
Affiliation as printed
Department of Medicine A, University Hospital Münster, Münster, Germany
-
Technische Universität Dresden
Affiliation as printed
Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany
-
Affiliation as printed
Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
-
Affiliation as printed
Department of Internal Medicine II, University Hospital Frankfurt, Frankfurt, Germany
-
Technische Universität Dresden
Affiliation as printed
Department of Internal Medicine I, University Hospital TU Dresden, Dresden, Germany
Cited by 16 stored of 16
16 results
No patents citing this paper on Lens.org (checked 2026-10-06).
References 23
-
W144898347details pending0citations
-
W1747478039details pending0citations
-
W1993862617details pending0citations
-
W2008474770details pending0citations
-
W2025086811details pending0citations
-
W2040334311details pending0citations
-
W2042814209details pending0citations
-
W2069448515details pending0citations
-
W2079025304details pending0citations
-
W2080076140details pending0citations
-
W2123986795details pending0citations
-
W2143174436details pending0citations
-
W2155480680details pending0citations
-
W2163112291details pending0citations
-
W2330718732details pending0citations